Skip to main content

Table 1 Demographic data of studied groups

From: Effect of long-term administration of clonazepam, carbamazepine, and valproate on cognitive, psychological, and personality changes in adult epilepsy: a case–control study

Variables

Group 1

N = 35

N (%)

Group 2

N=18

N (%)

Group 3

N = 31

N (%)

Group 4

N = 15

N (%)

Group 5

N = 40

N (%)

P value

Age (mean ±SE)

41.86 ± 12.56

27.83 ± 6.32

37.35 ± 8.63

34.80 ± 12.63

36.13 ± 11.13

0.002*

Sex

 Male

10 (28.6%)

15 (83.3%)

21 (67.7%)

6 (40%)

31 (51.5%)

0.001*

 Female

25 (71.4%)

3 (16.7%)

10 (32.3%)

9 (60%)

29 (48.3%)

 

Marital status

 Single

8 (22.9%)

9 (50%)

11 (35.5%)

3 (20%)

20 (33.3%)

0.03*

 Married

25 (71.4%)

9 (50%)

18 (58%)

9 (60%)

38 (63.3%)

 

 Divorce

0 (0%)

0 (0%)

2 (6.5%)

0 (0%)

0 (0%)

 

 Widow

2 (5.7%)

0 (0%)

0 (0%)

3 (20%)

2 (3.3%)

 

Education

 Illiterate

32 (91.4%)

6 (33.3%)

25 (80.6%)

9 (60%)

33 (55%)

0.000*

 Primary education

0 (0%)

0 (0%)

3 (9.7%)

0 (0%)

10 (16.7%)

 

 High education

3 (8.6%)

12 (66.7%)

3 (9.7%)

6 (40%)

17 (28.3%)

 

Occupation state

 Not working

28 (80%)

9 (50%)

17 (54.8%)

9 (60%)

33 (55%)

0.172

 Employers

7 (20%)

9 (50%)

14 (45.2%)

6 (40%)

27 (45%)

 
  1. Group 1: carbamazepine, group 2: valproate, group 3: carbamazepine and clonazepam, group 4: valproate and clonazepam, group 5: epileptic patients without antiepileptic drugs (AEDs), *significant P value